. For instance, according to the article titled “Organ donation in India – There is light at the end of the tunnel” published in 2022, it is projected that every year, approximately 5 lakh Indians face organ failures, still less than 2%-3% of them receive a life-saving transplant.
Asia Pacific artificial organs and bionics market is segmented into product, technology, material, end-user, company, and country. The product segment is further divided into artificial heart, artificial kidney, artificial thyroid gland, bionic limb, and others. Artificial kidneys held the dominant share in 2022, due to the increasing renal diseases, and failures, and growing elderly population. Based on country, Japan holds the maximum share of the market in the Asia Pacific region. This is attributed to the increase in the number of chronic diseases that lead to organ failure, rising older population, and increasing rate of road mishaps and resulting disabilities.
Major players in the artificial organs and bionics market of Asia Pacific include
Objective of the Study
- To analyze and forecast the market size of Asia Pacific artificialorgans and bionics market.
- To classify and forecast Asia Pacific artificial organs and bionicsmarket based on product, technology, material, end-user, company and country.
- To identify drivers and challenges for Asia Pacific artificial organsand bionics market.
- To examine competitive developments such as expansions, new productlaunches, mergers & acquisitions, etc., in Asia Pacific artificial organsand bionics market.
- To conduct pricing analysis for Asia Pacific artificial organs andbionics market.
- To identify and analyze the profile of leading players operating in AsiaPacific artificial organs and bionics market.
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of h
Market insights research calculated the market size of
Key Target Audience
- Hospitals, surgical centers, organbanks/distributors and other stakeholders
- Government bodiessuch as regulating authorities and policy makers
- Organizations,forums and alliances related to artificial organs and bionics
- Market researchand consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, Company share, Competitive landscape, Growth factors, and Trends |
| Segments covered | Product Technology Material End User Region |
| Country scope | China, India, Japan, South Korea, Singapore, Australia, Vietnam, Malaysia, Indonesia, Philippines |
| Key companies profiled | Medtronic plc, Getinge AB, Ekso Bionics Holdings Inc., Boston Scientific Corporation, ABIOMED, Rex Bionics Ltd, Össur hf, ReWalk Robotics, Cyberdyne Inc., and Obara Kogyo Inc. Ltd. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
